Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results

BACKGROUND: To evaluate clinical outcome after preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy and adjuvant chemotherapy for pathological stage UICC ≥ II. METHODS: 118 patients (median age 64 years; male : female ratio 2.5 : 1) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Guckenberger, Matthias, Wulf, Joern, Thalheimer, Andreas, Wehner, Daniel, Thiede, Arnulf, Müller, Gottfried, Sailer, Marco, Flentje, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806295/
https://www.ncbi.nlm.nih.gov/pubmed/20025752
http://dx.doi.org/10.1186/1748-717X-4-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806295/
https://www.ncbi.nlm.nih.gov/pubmed/20025752
http://dx.doi.org/10.1186/1748-717X-4-67

Ejemplares similares